U.S. Clinical Trial: Fate Therapeutics Listed a New Clinical Trial to Study FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Contify Life Science News. 2024.